Raia Financial Statements From 2010 to 2025
| RADL3 Stock | BRL 19.82 0.18 0.92% |
Check Raia Drogasil financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Raia Drogasil's main balance sheet or income statement drivers, such as , as well as many indicators such as . Raia financial statements analysis is a perfect complement when working with Raia Drogasil Valuation or Volatility modules.
Raia |
Raia Drogasil SA Company Return On Equity Analysis
Raia Drogasil's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Raia Drogasil Return On Equity | 0.18 |
Most of Raia Drogasil's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Raia Drogasil SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Raia Drogasil SA has a Return On Equity of 0.1825. This is 100.76% lower than that of the Food & Staples Retailing sector and significantly higher than that of the Consumer Staples industry. The return on equity for all Brazil stocks is 158.87% lower than that of the firm.
Raia Drogasil SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Raia Drogasil's current stock value. Our valuation model uses many indicators to compare Raia Drogasil value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Raia Drogasil competition to find correlations between indicators driving Raia Drogasil's intrinsic value. More Info.Raia Drogasil SA is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Raia Drogasil SA is roughly 2.74 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Raia Drogasil's earnings, one of the primary drivers of an investment's value.About Raia Drogasil Financial Statements
Raia Drogasil shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Raia Drogasil investors may analyze each financial statement separately, they are all interrelated. The changes in Raia Drogasil's assets and liabilities, for example, are also reflected in the revenues and expenses on on Raia Drogasil's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. The company was founded in 1905 and is headquartered in So Paulo, Brazil. RAIADROGASILON operates under Pharmaceutical Retailers classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 50320 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Raia Stock Analysis
When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.